Inflammatory Cytokine Levels Correlate with Amyloid Load in Transgenic Mouse Models of Alzheimer's Disease

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2005 Mar 15

PMID 15762998

Citations 143

Authors

Nikunj S Patel

Daniel Paris

Venkatarajan Mathura

Amita N Quadros

Fiona C Crawford

Michael J Mullan

Affiliations

Soon will be listed here.

Abstract

BACKGROUND: Inflammation is believed to play an important role in the pathology of Alzheimer's disease (AD) and cytokine production is a key pathologic event in the progression of inflammatory cascades. The current study characterizes the cytokine expression profile in the brain of two transgenic mouse models of AD (TgAPPsw and PS1/APPsw) and explores the correlations between cytokine production and the level of soluble and insoluble forms of Abeta. METHODS: Organotypic brain slice cultures from 15-month-old mice (TgAPPsw, PS1/APPsw and control littermates) were established and multiple cytokine levels were analyzed using the Bio-plex multiple cytokine assay system. Soluble and insoluble forms of Abeta were quantified and Abeta-cytokine relationships were analyzed. RESULTS: Compared to control littermates, transgenic mice showed a significant increase in the following pro-inflammatory cytokines: TNF-alpha, IL-6, IL-12p40, IL-1beta, IL-1alpha and GM-CSF. TNF-alpha, IL-6, IL-1alpha and GM-CSF showed a sequential increase from control to TgAPPsw to PS1/APPsw suggesting that the amplitude of this cytokine response is dependent on brain Abeta levels, since PS1/APPsw mouse brains accumulate more Abeta than TgAPPsw mouse brains. Quantification of Abeta levels in the same slices showed a wide range of Abeta soluble:insoluble ratio values across TgAPPsw and PS1/APPsw brain slices. Abeta-cytokine correlations revealed significant relationships between Abeta1-40, 1-42 (both soluble and insoluble) and all the above cytokines that changed in the brain slices. CONCLUSION: Our data confirm that the brains of transgenic APPsw and PS1/APPsw mice are under an active inflammatory stress, and that the levels of particular cytokines may be directly related to the amount of soluble and insoluble Abeta present in the brain suggesting that pathological accumulation of Abeta is a key driver of the neuroinflammatory response.

Citing Articles

Decoding Alzheimer's Disease With Depression: Molecular Insights and Therapeutic Target.

Li Z, Guo H, Ge Y, Li X, Dong F, Zhang F J Cell Mol Med. 2025; 29(5):e70454.

PMID: 40074694 PMC: 11903198. DOI: 10.1111/jcmm.70454.

TMF Attenuates Cognitive Impairment and Neuroinflammation by Inhibiting the MAPK/NF-κB Pathway in Alzheimer's Disease: A Multi-Omics Analysis.

Liu Y, Xu X, Wu X, Yang G, Luo J, Liang X Mar Drugs. 2025; 23(2).

PMID: 39997198 PMC: 11857128. DOI: 10.3390/md23020074.

Identification of RN7SK LncRNA as a novel biomarker in Alzheimer's disease using bioinformatics and expression analysis.

Kazemi M, Sadeh R, Shekari Khaniani M, Rezazadeh M, Mansoori Derakhshan S, Ghafouri-Fard S Sci Rep. 2024; 14(1):31192.

PMID: 39732800 PMC: 11682388. DOI: 10.1038/s41598-024-82490-9.

Unraveling the causative connection between urticaria, inflammatory cytokines, and mental disorders: Perspectives from genetic evidence.

Liu Z, Wang Y, Wang S, Wu J, Jia C, Tan X Skin Res Technol. 2024; 30(9):e13906.

PMID: 39300828 PMC: 11413335. DOI: 10.1111/srt.13906.

The role of macrophage plasticity in neurodegenerative diseases.

Ma H, Zhu M, Chen M, Li X, Feng X Biomark Res. 2024; 12(1):81.

PMID: 39135084 PMC: 11321226. DOI: 10.1186/s40364-024-00624-7.

References

Grace E, Rabiner C, Busciglio J . Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience. 2002; 114(1):265-73. DOI: 10.1016/s0306-4522(02)00241-5. View

Lim G, Yang F, Chu T, Chen P, BEECH W, Teter B . Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci. 2000; 20(15):5709-14. PMC: 6772529. View

Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P . Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett. 1995; 202(1-2):17-20. DOI: 10.1016/0304-3940(95)12192-7. View

Kawarabayashi T, Younkin L, Saido T, Shoji M, Ashe K, Younkin S . Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci. 2001; 21(2):372-81. PMC: 6763819. View

Mehlhorn G, Hollborn M, Schliebs R . Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci. 2000; 18(4-5):423-31. DOI: 10.1016/s0736-5748(00)00012-5. View

Brugg B, Dubreuil Y, Huber G, Wollman E, Delhaye-Bouchaud N, Mariani J . Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci U S A. 1995; 92(7):3032-5. PMC: 42353. DOI: 10.1073/pnas.92.7.3032. View

Quadros A, Patel N, Crescentini R, Crawford F, Paris D, Mullan M . Increased TNFalpha production and Cox-2 activity in organotypic brain slice cultures from APPsw transgenic mice. Neurosci Lett. 2003; 353(1):66-8. DOI: 10.1016/j.neulet.2003.08.076. View

Mrak R, Griffinbc W . The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol Aging. 2002; 22(6):915-22. DOI: 10.1016/s0197-4580(01)00293-7. View

Sciacca F, Ferri C, Licastro F, Veglia F, Biunno I, Gavazzi A . Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol Aging. 2003; 24(7):927-31. DOI: 10.1016/s0197-4580(03)00011-3. View

10.

Holcomb L, Gordon M, McGowan E, Yu X, Benkovic S, Jantzen P . Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998; 4(1):97-100. DOI: 10.1038/nm0198-097. View

11.

Giovannini M, Scali C, Prosperi C, Bellucci A, Vannucchi M, Rosi S . Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway. Neurobiol Dis. 2002; 11(2):257-74. DOI: 10.1006/nbdi.2002.0538. View

12.

Cacabelos R, Alvarez X, Fernandez-Novoa L, Franco A, Mangues R, Pellicer A . Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods Find Exp Clin Pharmacol. 1994; 16(2):141-51. View

13.

Griffin W, Stanley L, Ling C, White L, MacLeod V, Perrot L . Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989; 86(19):7611-5. PMC: 298116. DOI: 10.1073/pnas.86.19.7611. View

14.

Lambert M, Barlow A, Chromy B, Edwards C, Freed R, Liosatos M . Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998; 95(11):6448-53. PMC: 27787. DOI: 10.1073/pnas.95.11.6448. View

15.

Gitter B, Boggs L, May P, Czilli D, Carlson C . Regulation of cytokine secretion and amyloid precursor protein processing by proinflammatory amyloid beta (A beta). Ann N Y Acad Sci. 2001; 917:154-64. DOI: 10.1111/j.1749-6632.2000.tb05379.x. View

16.

Vehmas A, Kawas C, Stewart W, Troncoso J . Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging. 2002; 24(2):321-31. DOI: 10.1016/s0197-4580(02)00090-8. View

17.

Tarkowski E, Wallin A, Regland B, Blennow K, Tarkowski A . Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol Scand. 2001; 103(3):166-74. DOI: 10.1034/j.1600-0404.2001.103003166.x. View

18.

Del Bo R, Angeretti N, Lucca E, De Simoni M, Forloni G . Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett. 1995; 188(1):70-4. DOI: 10.1016/0304-3940(95)11384-9. View

19.

Prabhakar U, Eirikis E, Davis H . Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods. 2002; 260(1-2):207-18. DOI: 10.1016/s0022-1759(01)00543-9. View

20.

Du Y, Dodel R, Eastwood B, Bales K, Gao F, Lohmuller F . Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology. 2000; 55(4):480-3. DOI: 10.1212/wnl.55.4.480. View